Webinar dates: February 9, March 1, and April 5, 2024
Webinar time: 12-1:30pm EST
Jointly provided by Partners for Advancing Clinical Education (PACE) and New England HIMSS (NE HIMSS)
Join New England HIMSS Clinical Informatics Council for a series exploring AI in the clinical world.
Intended Audiences
This activity is intended for physicians, nurses, mid-levels and pharmacists who care for patients and use artificial intelligence tools.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Discuss the diverse applications of AI in healthcare, including its role in diagnostics, treatment planning, personalized medicine, predictive analytics, and administrative processes, to effectively integrate these technologies into clinical practices and enhance overall patient care.
- Navigate and comply with regulatory frameworks, including HIPAA guidance and FDA regulations, to ensure the secure and privacy-compliant implementation of AI-driven solutions.
- Develop skills in adopting and integrating emerging technologies such as Hospital at Home programs and evaluate their impact on improving patient care and accessibility.
- Describe the ethical considerations surrounding AI in healthcare, addressing issues of bias, fairness, transparency, and patient consent.
There will be 3 sessions from 12-1:30pm.
- February 9th - The Generation of AI
- March 1st - The Legality of AI
- April 5th - The Future of AI
Ticket prices are inclusive of all 3 sessions.
- $35 members
- $55 non-members
- $35 NENIC members
Faculty and Disclosures
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.
Faculty |
Conflicts of Interest |
Lecia Sequist, MD - Medical Oncologist, Mass General Hospital |
Has no relevant financial relationship(s) with ineligible companies to disclose. |
Ramin Khorasani, MD, MPH - Vice Chair, Department of Radiology, Brigham and Women’s Hospital |
Has no relevant financial relationship(s) with ineligible companies to disclose. |
Amy Berk, MSN, RN - Director Population Health, Microsoft |
Has no relevant financial relationship(s) with ineligible companies to disclose. |
Lisa Lehmann, MD - Director of the Center for Bioethics, Brigham and Women’s Hospital |
Employee for Google |
Rebecca Winokur, MD, MPH - Physician executive and Health Justice Leader |
Has no relevant financial relationship(s) with ineligible companies to disclose. |
Amy Joseph, JD - Partner, Hooper Lundy Bookman |
Has no relevant financial relationship(s) with ineligible companies to disclose. |
Jeremy Sherer, JD - Partner, Hooper Lundy Bookman |
Has no relevant financial relationship(s) with ineligible companies to disclose. |
Caroline Yang, MD - Associate Clinical Director, Hospital at Home, Mass General Brigham |
Has no relevant financial relationship(s) with ineligible companies to disclose. |
Samuel (Sandy) Aronson, MD - Executive Director of IT at Partners Personalized Medicine, Mass General Brigham |
Consultant, Advisor, Speaker for Nest Genomics; Google; Multiple pharmaceutical and device companies. |
Julius Bogdan - VP & GM, Digital Health Advisory, HIMSS |
Has no relevant financial relationship(s) with ineligible companies to disclose. |
Diane Menasco, RN, MSHI - Director of Informatics, MGB Salem Hospital |
Has no relevant financial relationship(s) with ineligible companies to disclose. |
Rebecca Mishuris, MD, MPH - Chief Medical Information Officer and VP, Mass General Brigham |
Consultant, Advisor, Speaker for Elsevier. |
Joint Accreditation Statement
|
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and New England HIMSS. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Physician Continuing Education
PACE designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 4.5 contact hours.
Pharmacy Continuing Education
PACE designates this continuing education activity for 4.5 contact hour(s) (0.45 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008073-9999-24-017-L04-P
Type of Activity: Knowledge
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Pharmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check your NABP account within thirty (30) days to make sure the credit has posted.
PA Continuing Medical Education
|
PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. |